Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats

BMC Bioinformatics

Volumn 7, Issue SUPPL.2, 2006, Pages

  Chen, Tao ^a   Guo, Lei ^a   Zhang, Lu ^b,d   Shi, Leming ^a   Fang, Hong ^c   Sun, Yongming ^b   Fuscoe, James C ^a   Mei, Nan ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b APPLIED BIOSYSTEMS   (United States)

^c Z Tech Corporation   (United States)

^d Solexa Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; CARCINOGENIC EFFECTS; DIFFERENTIAL RESPONSE; EXPRESSION PROFILE; GENE EXPRESSION PROFILES; HIERARCHICAL CLUSTER ANALYSIS; MICROARRAY ANALYSIS; PRINCIPAL COMPONENTS ANALYSIS;

BIOLOGICAL ORGANS; CELL DEATH; CLUSTER ANALYSIS; DISEASES; FUNCTIONAL ANALYSIS; GENE EXPRESSION; HIERARCHICAL SYSTEMS; HISTOLOGY; IMMUNE SYSTEM; PRINCIPAL COMPONENT ANALYSIS; RATS; TOXICITY; TUMORS;

ASCORBIC ACID;

ARISTOLOCHIC ACID; PLACEBO; ARISTOLOCHIC ACID I; CARCINOGEN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DRUG EXPOSURE; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; KIDNEY; LIVER; MALE; MICROARRAY ANALYSIS; MUTATION; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; RAT; TISSUE SPECIFICITY; TRANSGENIC RAT; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGY; BIOMETRY; DRUG EFFECT; FISCHER 344 RAT; GENE EXPRESSION REGULATION; METABOLISM;

ARISTOLOCHIA; RATTUS; RODENTIA;

ANIMALS; ARISTOLOCHIC ACIDS; BIOMETRY; CARCINOGENS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY; LIVER; ORGAN SPECIFICITY; RATS; RATS, INBRED F344;

EID: 33947317378     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-S2-S20     Document Type: Article

References (35)

1. Arlt VM, Stiborova M, Schmeiser HH: Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002, 17(4):265-277.
2. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, et al.: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993, 341(8842):387-391.
3. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C: Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994, 45(6):1680-1688.
4. Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL: Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994, 24(2):172-180.
5. Vanherweghem LJ: Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998, 4(1):9-13.
6. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL: Identification of aristolochic acid in Chinese herbs. Lancet 1994, 343(8890):174.
7. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, et al.: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000, 342(23):1686-1692.
8. Vanherweghem JL, Tielemans C, Simon J, Depierreux M: Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant 1995, 10(2):270-273.
9. Mengs U: Acute toxicity of aristolochic acid in rodents. Arch Toxicol 1987, 59(5):328-331.
10. Mengs U: Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 1988, 61(6):504-505.
11. Mengs U, Lang W, Poch I: The crcinogenic action of aristolochic acid in rats. Arch Toxicol 1982, 51:107-119.
12. Mengs U: On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol 1983, 52(3):209-220.
13. Gold L, Zeiger E, (eds): Handbook of carcinogenic potency and genotoxicity databases. Boca Raton, Fla 1997 [http://potency.berkeley.edu/]. CRC Press
14. IARC: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. In IARC monographs on the evaluation of carcinogenic risk of chemicals to humans Volume 82. Lyons, France: IARC Press; 2002.
15. Schwetz BA: From the Food and Drug Administration. Jama 2001, 285(212705 [http://www.cfsan.fda.gov/~dms/ds-bot.html].
16. Gold LS, Slone TH: Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N Engl J Med 2003, 349(16):1576-1577.
17. Stiborova M, Frei E, Hodek P, Wiessler M, Schmeiser HH: Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer. Int J Cancer 2005, 113(2):189-197.
18. Fernando RC, Schmeiser HH, Scherf HR, Wiessler M: Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci Publ 1993, 124:167-171.
19. Pfau W, Schmeiser HH, Wiessler M: 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis 1990, 11(9):1627-1633.
20. Schmeiser HH, Pool BL, Wiessler M: Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 1986, 7(1):59-63.
21. Wang A, Gehan EA: Gene selection for microarray data analysis using principal component analysis. Stat Med 2005, 24(13):2069-2087.
22. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, et al.: The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004, 32(Database):D258-261.
23. Su Z, Xu S, Zheng F, Li Y: [Aristolochic acid induced transdifferentiation and apoptosis in human tubular epithelial cells in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi 2002, 36(5):301-304.
24. Gao R, Zheng F, Liu Y, Zheng D, Li X, Bo Y: Aristolochic acid I-induced apoptosis in LLC-PK1 cells and amelioration of the apoptotic damage by calcium antagonist. Chin Med J (Engl) 2000, 113(5):418-424.
25. Fall CP, Bennett JP Jr: MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid. Brain Res 1998, 811(1-2):143-146.
26. Liu MC, Maruyama S, Mizuno M, Morita Y, Hanaki S, Yuzawa Y, Matsuo S: The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. Clin Exp Nephrol 2003, 7(3):186-194.
27. White E, Chiou SK, Rao L, Sabbatini P, Lin HJ: Control of p53-dependent apoptosis by E1B, Bcl-2, and Ha-ras proteins. Cold Spring Harb Symp Quant Biol 1994, 59:395-402.
28. Hendry BM, Khwaja A, Qu QY, Shankland SJ: Distinct functions for Ras GTPases in the control of proliferation and apoptosis in mouse and human mesangial cells. Kidney Int 2006, 69(1):99-104.
29. Varghese HJ, Davidson MT, MacDonald IC, Wilson SM, Nadkarni KV, Groom AC, Chambers AF: Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res 2002, 62(3):887-891.
30. Shav-Tal Y, Zipori D: The role of activin a in regulation of hemopoiesis. Stem Cells 2002, 20(6):493-500.
31. Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W: Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 2006, 5(4):995-1002.
32. Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, et al.: ArrayTrack - supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 2003, 111(15):1819-1826.
33. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98(9):5116-5121.
34. Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, et al.: Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 2004, 549(1-2241-253 [http://www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/].
35. IPA: 2006 [http://www.ingenuity.com].